Large‐scale blood group genotyping – clinical implications
Summary The molecular background of blood group antigen expression of the major clinically significant blood group antigens has been largely accomplished. Despite this large body of work, blood group phenotype prediction by genotyping has a marginal supporting role in the routine blood bank. It has...
Gespeichert in:
| Veröffentlicht in: | British journal of haematology 2009-01, Vol.144 (1), p.3-13 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 13 |
|---|---|
| container_issue | 1 |
| container_start_page | 3 |
| container_title | British journal of haematology |
| container_volume | 144 |
| creator | Avent, Neil D. |
| description | Summary
The molecular background of blood group antigen expression of the major clinically significant blood group antigens has been largely accomplished. Despite this large body of work, blood group phenotype prediction by genotyping has a marginal supporting role in the routine blood bank. It has however had a major impact in the prenatal determination of fetal blood group status in the management of haemolytic disease of the fetus and newborn. In the past few years several high throughput systems have been in development that have the potential capacity to perform genotyping on a mass scale. Such systems have been designed for use on donor‐ and patient‐derived DNA and provide much more comprehensive information regarding an individuals blood group than is possible by using serological methods alone. DNA‐based typing methodology is easier to standardize than serology and has the potential to replace it as a front line diagnostic in blood banks. This review overviews the current situation in this area and attempts to predict how blood group genotyping will evolve in the future. |
| doi_str_mv | 10.1111/j.1365-2141.2008.07285.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_746305361</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66741498</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4795-419febb266f96e1ee9723a93b7832c41a0fa9d5cfba731bfd4743b671ad223863</originalsourceid><addsrcrecordid>eNqNkLFOwzAQhi0EoqXwCigLMCX4bMeOB5CgAgqqxAKz5SRO5SpNQtyKdusjIPGGfRIcWsGG8OKT7vt95w-hAHAE_lxOI6A8DgkwiAjGSYQFSeJouYf6P4191McYixAwS3royLkpxkBxDIeoBxIDF5T10fVYtxOzWX-4TJcmSMu6zoNJWy-aYGKqer5qbDUJNuvPICttZT0U2FlT-mJu68odo4NCl86c7O4Ber2_exmOwvHzw-PwZhxmTMg4ZCALk6aE80JyA8ZIQaiWNBUJJRkDjQst8zgrUi0opEXOBKMpF6BzQmjC6QBdbN9t2vptYdxczazLTFnqytQLpwTj_muUgyfP_yQ5FwyYTDyYbMGsrZ1rTaGa1s50u1KAVWdZTVUnU3UyVWdZfVtWSx893c1YpDOT_wZ3Wj1wtgN057VodZVZ98MRLJkAKjx3teXebWlW_15A3T6Nuop-AVF5mOY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66741498</pqid></control><display><type>article</type><title>Large‐scale blood group genotyping – clinical implications</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Avent, Neil D.</creator><creatorcontrib>Avent, Neil D.</creatorcontrib><description>Summary
The molecular background of blood group antigen expression of the major clinically significant blood group antigens has been largely accomplished. Despite this large body of work, blood group phenotype prediction by genotyping has a marginal supporting role in the routine blood bank. It has however had a major impact in the prenatal determination of fetal blood group status in the management of haemolytic disease of the fetus and newborn. In the past few years several high throughput systems have been in development that have the potential capacity to perform genotyping on a mass scale. Such systems have been designed for use on donor‐ and patient‐derived DNA and provide much more comprehensive information regarding an individuals blood group than is possible by using serological methods alone. DNA‐based typing methodology is easier to standardize than serology and has the potential to replace it as a front line diagnostic in blood banks. This review overviews the current situation in this area and attempts to predict how blood group genotyping will evolve in the future.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/j.1365-2141.2008.07285.x</identifier><identifier>PMID: 19016734</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>alloimmunization ; Antigens ; Biological and medical sciences ; blood group antigens ; Blood Group Antigens - genetics ; Blood Grouping and Crossmatching - methods ; Diseases of mother, fetus and pregnancy ; Female ; Genotype ; genotyping ; Gynecology. Andrology. Obstetrics ; Hematologic and hematopoietic diseases ; high throughput ; Humans ; Infant, Newborn ; Mass Screening - instrumentation ; Mass Screening - methods ; Medical sciences ; Oligonucleotide Array Sequence Analysis - instrumentation ; Oligonucleotide Array Sequence Analysis - methods ; Pregnancy ; Pregnancy. Fetus. Placenta</subject><ispartof>British journal of haematology, 2009-01, Vol.144 (1), p.3-13</ispartof><rights>2008 The Author. Journal Compilation © 2008 Blackwell Publishing Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4795-419febb266f96e1ee9723a93b7832c41a0fa9d5cfba731bfd4743b671ad223863</citedby><cites>FETCH-LOGICAL-c4795-419febb266f96e1ee9723a93b7832c41a0fa9d5cfba731bfd4743b671ad223863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2141.2008.07285.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2141.2008.07285.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,4010,27900,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20947137$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19016734$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Avent, Neil D.</creatorcontrib><title>Large‐scale blood group genotyping – clinical implications</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary
The molecular background of blood group antigen expression of the major clinically significant blood group antigens has been largely accomplished. Despite this large body of work, blood group phenotype prediction by genotyping has a marginal supporting role in the routine blood bank. It has however had a major impact in the prenatal determination of fetal blood group status in the management of haemolytic disease of the fetus and newborn. In the past few years several high throughput systems have been in development that have the potential capacity to perform genotyping on a mass scale. Such systems have been designed for use on donor‐ and patient‐derived DNA and provide much more comprehensive information regarding an individuals blood group than is possible by using serological methods alone. DNA‐based typing methodology is easier to standardize than serology and has the potential to replace it as a front line diagnostic in blood banks. This review overviews the current situation in this area and attempts to predict how blood group genotyping will evolve in the future.</description><subject>alloimmunization</subject><subject>Antigens</subject><subject>Biological and medical sciences</subject><subject>blood group antigens</subject><subject>Blood Group Antigens - genetics</subject><subject>Blood Grouping and Crossmatching - methods</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Female</subject><subject>Genotype</subject><subject>genotyping</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Hematologic and hematopoietic diseases</subject><subject>high throughput</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Mass Screening - instrumentation</subject><subject>Mass Screening - methods</subject><subject>Medical sciences</subject><subject>Oligonucleotide Array Sequence Analysis - instrumentation</subject><subject>Oligonucleotide Array Sequence Analysis - methods</subject><subject>Pregnancy</subject><subject>Pregnancy. Fetus. Placenta</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkLFOwzAQhi0EoqXwCigLMCX4bMeOB5CgAgqqxAKz5SRO5SpNQtyKdusjIPGGfRIcWsGG8OKT7vt95w-hAHAE_lxOI6A8DgkwiAjGSYQFSeJouYf6P4191McYixAwS3royLkpxkBxDIeoBxIDF5T10fVYtxOzWX-4TJcmSMu6zoNJWy-aYGKqer5qbDUJNuvPICttZT0U2FlT-mJu68odo4NCl86c7O4Ber2_exmOwvHzw-PwZhxmTMg4ZCALk6aE80JyA8ZIQaiWNBUJJRkDjQst8zgrUi0opEXOBKMpF6BzQmjC6QBdbN9t2vptYdxczazLTFnqytQLpwTj_muUgyfP_yQ5FwyYTDyYbMGsrZ1rTaGa1s50u1KAVWdZTVUnU3UyVWdZfVtWSx893c1YpDOT_wZ3Wj1wtgN057VodZVZ98MRLJkAKjx3teXebWlW_15A3T6Nuop-AVF5mOY</recordid><startdate>200901</startdate><enddate>200901</enddate><creator>Avent, Neil D.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>200901</creationdate><title>Large‐scale blood group genotyping – clinical implications</title><author>Avent, Neil D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4795-419febb266f96e1ee9723a93b7832c41a0fa9d5cfba731bfd4743b671ad223863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>alloimmunization</topic><topic>Antigens</topic><topic>Biological and medical sciences</topic><topic>blood group antigens</topic><topic>Blood Group Antigens - genetics</topic><topic>Blood Grouping and Crossmatching - methods</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Female</topic><topic>Genotype</topic><topic>genotyping</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Hematologic and hematopoietic diseases</topic><topic>high throughput</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Mass Screening - instrumentation</topic><topic>Mass Screening - methods</topic><topic>Medical sciences</topic><topic>Oligonucleotide Array Sequence Analysis - instrumentation</topic><topic>Oligonucleotide Array Sequence Analysis - methods</topic><topic>Pregnancy</topic><topic>Pregnancy. Fetus. Placenta</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Avent, Neil D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Avent, Neil D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Large‐scale blood group genotyping – clinical implications</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2009-01</date><risdate>2009</risdate><volume>144</volume><issue>1</issue><spage>3</spage><epage>13</epage><pages>3-13</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>Summary
The molecular background of blood group antigen expression of the major clinically significant blood group antigens has been largely accomplished. Despite this large body of work, blood group phenotype prediction by genotyping has a marginal supporting role in the routine blood bank. It has however had a major impact in the prenatal determination of fetal blood group status in the management of haemolytic disease of the fetus and newborn. In the past few years several high throughput systems have been in development that have the potential capacity to perform genotyping on a mass scale. Such systems have been designed for use on donor‐ and patient‐derived DNA and provide much more comprehensive information regarding an individuals blood group than is possible by using serological methods alone. DNA‐based typing methodology is easier to standardize than serology and has the potential to replace it as a front line diagnostic in blood banks. This review overviews the current situation in this area and attempts to predict how blood group genotyping will evolve in the future.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19016734</pmid><doi>10.1111/j.1365-2141.2008.07285.x</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1048 |
| ispartof | British journal of haematology, 2009-01, Vol.144 (1), p.3-13 |
| issn | 0007-1048 1365-2141 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_746305361 |
| source | Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | alloimmunization Antigens Biological and medical sciences blood group antigens Blood Group Antigens - genetics Blood Grouping and Crossmatching - methods Diseases of mother, fetus and pregnancy Female Genotype genotyping Gynecology. Andrology. Obstetrics Hematologic and hematopoietic diseases high throughput Humans Infant, Newborn Mass Screening - instrumentation Mass Screening - methods Medical sciences Oligonucleotide Array Sequence Analysis - instrumentation Oligonucleotide Array Sequence Analysis - methods Pregnancy Pregnancy. Fetus. Placenta |
| title | Large‐scale blood group genotyping – clinical implications |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T03%3A25%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Large%E2%80%90scale%20blood%20group%20genotyping%20%E2%80%93%20clinical%20implications&rft.jtitle=British%20journal%20of%20haematology&rft.au=Avent,%20Neil%20D.&rft.date=2009-01&rft.volume=144&rft.issue=1&rft.spage=3&rft.epage=13&rft.pages=3-13&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/j.1365-2141.2008.07285.x&rft_dat=%3Cproquest_cross%3E66741498%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66741498&rft_id=info:pmid/19016734&rfr_iscdi=true |